The selection and function of cell type-specific enhancers

Sven Heinz; Casey E. Romanoski; Christopher Benner; Christopher K. Glass

doi:10.1038/nrm3949

journal article Feb 04, 2015

The selection and function of cell type-specific enhancers

Sven Heinz

Casey E. Romanoski Christopher Benner

Christopher K. Glass

Nature Reviews Molecular Cell Biology Vol. 16 No. 3 pp. 144-154 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nrm3949

Topics

No keywords indexed for this article. Browse by subject →

References

128

[1]

Banerji, J., Rusconi, S. & Schaffner, W. Expression of a β-globin gene is enhanced by remote SV40 DNA sequences. Cell 27, 299–308 (1981). 10.1016/0092-8674(81)90413-x

[2]

Lettice, L. A. et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum. Mol. Genet. 12, 1725–1735 (2003). 10.1093/hmg/ddg180

[3]

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

Nathaniel D Heintzman, Rhona K Stuart, Gary Hon et al.

Nature Genetics 2007 10.1038/ng1966

[4]

Carroll, J. S. et al. Genome-wide analysis of estrogen receptor binding sites. Nature Genet. 38, 1289–1297 (2006). 10.1038/ng1901

[5]

Barish, G. D. et al. Bcl-6 and NF-κB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 24, 2760–2765 (2010). 10.1101/gad.1998010

[6]

John, S. et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nature Genet. 43, 264–268 (2011). 10.1038/ng.759

[7]

Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities

Sven Heinz, Christopher Benner, Nathanael Spann et al.

Molecular Cell 2010 10.1016/j.molcel.2010.05.004

[8]

Lefterova, M. I. et al. Cell-specific determinants of peroxisome proliferator-activated receptor γ function in adipocytes and macrophages. Mol. Cell. Biol. 30, 2078–2089 (2010). 10.1128/mcb.01651-09

[9]

Nielsen, R. et al. Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 22, 2953–2967 (2008). 10.1101/gad.501108

[10]

Ghisletti, S. et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32, 317–328 (2010). This paper shows that PU.1 is an LDTF necessary for priming signal-dependent enhancers in macrophages, which defines their transcriptional response to inflammatory stimuli. 10.1016/j.immuni.2010.02.008

[11]

In vivo enhancer analysis of human conserved non-coding sequences

Len A. Pennacchio, Nadav Ahituv, Alan M. Moses et al.

Nature 2006 10.1038/nature05295

[12]

Woolfe, A. et al. Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biol. 3, e7 (2005). 10.1371/journal.pbio.0030007

[13]

Heintzman, N. D. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108–112 (2009). 10.1038/nature07829

[14]

ChIP-seq accurately predicts tissue-specific activity of enhancers

Axel Visel, Matthew J. Blow, Zirong Li et al.

Nature 2009 10.1038/nature07730

[15]

Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75–82 (2012). 10.1038/nature11232

[16]

An integrated encyclopedia of DNA elements in the human genome

Nature 2012 10.1038/nature11247

[17]

West, J. A. et al. Nucleosomal occupancy changes locally over key regulatory regions during cell differentiation and reprogramming. Nature Commun. 5, 4719 (2014). 10.1038/ncomms5719

[18]

Chan, H. M. & La Thangue, N. B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114, 2363–2373 (2001). 10.1242/jcs.114.13.2363

[19]

De Santa, F. et al. A large fraction of extragenic RNA Pol II transcription sites overlap enhancers. PLoS Biol. 8, e1000384 (2010). 10.1371/journal.pbio.1000384

[20]

Kim, T.-K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182–187 (2010). References 19 and 20 report the existence of widespread transcription at enhancers, which correlates with the transcription of neighbouring genes. 10.1038/nature09033

[21]

Stadler, M. B. et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480, 490–495 (2011). 10.1038/nature10716

[22]

Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nature Biotech. 28, 817–825 (2010). 10.1038/nbt.1662

[23]

He, H. H. et al. Nucleosome dynamics define transcriptional enhancers. Nature Genet. 42, 343–347 (2010). 10.1038/ng.545

[24]

Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279–283 (2011). 10.1038/nature09692

[25]

Histone H3K27ac separates active from poised enhancers and predicts developmental state

Menno P. Creyghton, Albert W. Cheng, G. Grant Welstead et al.

Proceedings of the National Academy of Sciences 2010 10.1073/pnas.1016071107

[26]

Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions

Gabriel E. Zentner, Paul J. Tesar, Peter C. Scacheri

Genome Research 2011 10.1101/gr.122382.111

[27]

Calo, E. & Wysocka, J. Modification of enhancer chromatin: what, how, and why? Mol. Cell 49, 825–837 (2013). 10.1016/j.molcel.2013.01.038

[28]

Gottgens, B. et al. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5′ bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1. Mol. Cell. Biol. 24, 1870–1883 (2004). 10.1128/mcb.24.5.1870-1883.2004

[29]

Sanchez, M. et al. An SCL 3′ enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development 126, 3891–3904 (1999). 10.1242/dev.126.17.3891

[30]

Delabesse, E. et al. Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo. Mol. Cell. Biol. 25, 5215–5225 (2005). 10.1128/mcb.25.12.5215-5225.2005

[31]

Zaret, K. S. et al. Pioneer factors, genetic competence, and inductive signaling: programming liver and pancreas progenitors from the endoderm. Cold Spring Harb. Symp. Quant. Biol. 73, 119–126 (2008). 10.1101/sqb.2008.73.040

[32]

Pham, T. H. et al. Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1. Nucleic Acids Res. 41, 6391–6402 (2013). 10.1093/nar/gkt355

[33]

Adams, C. C. & Workman, J. L. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol. Cell. Biol. 15, 1405–1421 (1995). 10.1128/mcb.15.3.1405

[34]

Boyes, J. & Felsenfeld, G. Tissue-specific factors additively increase the probability of the all-or-none formation of a hypersensitive site. EMBO J. 15, 2496–2507 (1996). 10.1002/j.1460-2075.1996.tb00607.x

[35]

Hoffman, B. G. et al. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res. 20, 1037–1051 (2010). 10.1101/gr.104356.109

[36]

Samstein, R. M. et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153–166 (2012). 10.1016/j.cell.2012.06.053

[37]

Shlyueva, D. et al. Hormone-responsive enhancer-activity maps reveal predictive motifs, indirect repression, and targeting of closed chromatin. Mol. Cell 54, 180–192 (2014). 10.1016/j.molcel.2014.02.026

[38]

Vahedi, G. et al. STATs shape the active enhancer landscape of T cell populations. Cell 151, 981–993 (2012). 10.1016/j.cell.2012.09.044

[39]

Xu, J. et al. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Dev. Cell. 23, 796–811 (2012). 10.1016/j.devcel.2012.09.003

[40]

Soufi, A., Donahue, G. & Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994–1004 (2012). 10.1016/j.cell.2012.09.045

[41]

Scott, E. W., Simon, M. C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573–1577 (1994). 10.1126/science.8079170

[42]

Kazemian, M., Pham, H., Wolfe, S. A., Brodsky, M. H. & Sinha, S. Widespread evidence of cooperative DNA binding by transcription factors in Drosophila development. Nucleic Acids Res. 41, 8237–8252 (2013). 10.1093/nar/gkt598

[43]

Heinz, S. et al. Effect of natural genetic variation on enhancer selection and function. Nature 503, 487–492 (2013). 10.1038/nature12615

[44]

Stefflova, K. et al. Cooperativity and rapid evolution of cobound transcription factors in closely related mammals. Cell 154, 530–540 (2013). 10.1016/j.cell.2013.07.007

[45]

Trompouki, E. et al. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 147, 577–589 (2011). 10.1016/j.cell.2011.09.044

[46]

Yanez-Cuna, J. O., Dinh, H. Q., Kvon, E. Z., Shlyueva, D. & Stark, A. Uncovering cis-regulatory sequence requirements for context-specific transcription factor binding. Genome Res. 22, 2018–2030 (2012). 10.1101/gr.132811.111

[47]

Mercer, E. M. et al. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35, 413–425 (2011). 10.1016/j.immuni.2011.06.013

[48]

Mullen, A. C. et al. Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell 147, 565–576 (2011). References 36 and 48 show that SDTFs bind to open chromatin regions that are defined by combinations of LDTFs. 10.1016/j.cell.2011.08.050

[49]

Carroll, J. S. et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33–43 (2005). 10.1016/j.cell.2005.05.008

[50]

Kaikkonen, M. U. et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 51, 310–325 (2013). This paper shows that the SDTF NF-κB contributes to the de novo priming (and activation) of enhancers in conjunction with LDTFs, and that transcription elongation is required for the methylation of the flanking H3K4 by MLL3 and MLL4. 10.1016/j.molcel.2013.07.010

Showing 50 of 128 references

Cited By

993

XLID syndrome gene Med12 promotes Ig isotype switching through chromatin modification and enhancer RNA regulation

Farazul Haque, Tasuku Honjo · 2022

Science Advances

Loss of Epigenetic Information as a Cause of Mammalian Aging

Jae-Hyun Yang, Motoshi Hayano · 2021

SSRN Electronic Journal

Towards a comprehensive catalogue of validated and target-linked human enhancers

Molly Gasperini, Jacob M. Tome · 2020

Nature Reviews Genetics

Chromatin Regulation of Neuronal Maturation and Plasticity

David A. Gallegos, Urann Chan · 2018

Trends in Neurosciences

Unique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL

M. Onal, H. C. St. John · 2015

Endocrinology

Metrics

993

Citations

128

References

Details

Published: Feb 04, 2015
Vol/Issue: 16(3)
Pages: 144-154
License: View

Authors

Cite This Article

Sven Heinz, Casey E. Romanoski, Christopher Benner, et al. (2015). The selection and function of cell type-specific enhancers. Nature Reviews Molecular Cell Biology, 16(3), 144-154. https://doi.org/10.1038/nrm3949

The selection and function of cell type-specific enhancers

You May Also Like